This inventor holds 1 USPTO granted patent. Top assignees: Gosudarsvenny Nauchy Tsentr Rossiiskoi Federatsii 'Niopik', Institut Elementoorganicheskikh Soedineny Rossiiskoi Akademii Nauk, Moskovsky Naucho-Issledovatelsky Onkologichesky Institut. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 1999
Title: Mark Efimovich Volpin: A Legacy in Tumor Growth Suppression
Introduction: Mark Efimovich Volpin, a talented inventor from Moscow, Russia, made significant contributions to the field of cancer research during his career. Known for his innovative approach to tumor growth suppression, his sole patent reflects his dedication to advancing medical science and improving patient outcomes.
Latest Patents: Volpin holds a patent for an "Agent for Suppressing Tumor Growth," which showcases his innovative strategies for combating cancer. This patent represents an essential step in the continuum of cancer treatment and is a testament to his scientific ingenuity.
Career Highlights: His professional journey included notable positions at institutions such as the Institute of Elemento-organic Compounds of the Russian Academy of Sciences and the State Scientific Center of the Russian Federation "NIOPIK." Throughout his career, Volpin's research focused on utilizing chemical compounds to inhibit tumor development effectively.
Collaborations: Volpin collaborated with esteemed colleagues, including Georgy Nikolaevich Vorozhtsov and Nadezhda Jurievna Krainova. These partnerships enriched his research endeavors and fostered a collaborative environment that promoted innovative solutions in cancer treatment.
Conclusion: Mark Efimovich Volpin's contributions to the field of medicine through his patented work demonstrate his lasting impact on cancer research. His legacy serves as an inspiration for future inventors and scientists dedicated to finding innovative solutions to complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile